nasopharyngeal carcinoma
FDA Approves Penpulimab for Non-Keratinizing Nasopharyngeal Carcinoma
The FDA has approved penpulimab-kcqx (Akeso Biopharma) with cisplatin or carboplatin and gemcitabine for the ...
APRIL 25, 2025
FDA Approves Loqtorz for Nasopharyngeal Carcinoma
The FDA approved toripalimab-tpzi (Loqtorz, Coherus BioSciences) with cisplatin and gemcitabine for the first-line ...
OCTOBER 30, 2023
Load more